Steele Memorial Medical Center | |
203 South Daisy Street, Salmon, Idaho 83467 | |
(208) 756-5600 | |
Not Available |
Name | Steele Memorial Medical Center |
---|---|
Type | Critical Access Hospital |
Location | 203 South Daisy Street, Salmon, Idaho |
Ownership | Government - Local |
Emergency Services | Yes |
Medicare ID (CCN) | 131305 |
NPI Number | 1851403265 |
Organization Name | STEELE MEMORIAL MEDICAL CENTER |
Address | 203 S Daisy St, Salmon, ID 83467 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 208-756-5600 |
News Archive
A team of scientists and doctors from the SingHealth Duke-NUS Academic Medical Centre has uncovered a new group of regulatory T (Treg) cells and DNA features associated with juvenile idiopathic arthritis (JIA), the most common form of arthritis among children under the age of 16.
Sirion Therapeutics, Inc. announced today that its supplemental New Drug Application (sNDA) submitted to the U.S. Food and Drug Administration (FDA) seeking market approval of Durezol(TM) (difluprednate ophthalmic emulsion) 0.05% to treat endogenous anterior uveitis has been accepted for review.
Danaher Corporation today announced record results for the second quarter 2015. For the quarter ended July 3, 2015, non-GAAP adjusted diluted net earnings per share were $1.08, which reflects the adjustments identified in the attached reconciliation schedule. On a GAAP basis, diluted net earnings for the second quarter were $696 million, or $0.97 per share. Revenue for the second quarter 2015 increased 3.5% to $5.1 billion with core revenues also increasing 3.5%.
For soldiers who have suffered a head injury, it can be frustrating when problems linger after returning home. Because there may be no physical signs of injury, issues like memory complaints or sleep disturbances that follow mild traumatic brain injury can be underestimated or overlooked by veterans and their families.
› Verified 3 days ago
Able to receive lab results electronically | Not Available |
Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
A team of scientists and doctors from the SingHealth Duke-NUS Academic Medical Centre has uncovered a new group of regulatory T (Treg) cells and DNA features associated with juvenile idiopathic arthritis (JIA), the most common form of arthritis among children under the age of 16.
Sirion Therapeutics, Inc. announced today that its supplemental New Drug Application (sNDA) submitted to the U.S. Food and Drug Administration (FDA) seeking market approval of Durezol(TM) (difluprednate ophthalmic emulsion) 0.05% to treat endogenous anterior uveitis has been accepted for review.
Danaher Corporation today announced record results for the second quarter 2015. For the quarter ended July 3, 2015, non-GAAP adjusted diluted net earnings per share were $1.08, which reflects the adjustments identified in the attached reconciliation schedule. On a GAAP basis, diluted net earnings for the second quarter were $696 million, or $0.97 per share. Revenue for the second quarter 2015 increased 3.5% to $5.1 billion with core revenues also increasing 3.5%.
For soldiers who have suffered a head injury, it can be frustrating when problems linger after returning home. Because there may be no physical signs of injury, issues like memory complaints or sleep disturbances that follow mild traumatic brain injury can be underestimated or overlooked by veterans and their families.
› Verified 3 days ago
Steele Memorial Medical Center Critical Access Hospital Location: 203 South Daisy Street, Salmon, Idaho 83467 Phone: (208) 756-5600 |